End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,020 INR | +0.05% |
|
+1.19% | -36.31% |
03/05 | Transcript : Tatva Chintan Pharma Chem Limited, Q4 2024 Earnings Call, May 03, 2024 | |
03/05 | Tatva Chintan Pharma Chem Limited Recommends Final Dividend for the Financial Year 2023-2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.31% | 29Cr | |
+22.27% | 6.95TCr | |
-6.65% | 4.57TCr | |
+24.31% | 4.46TCr | |
+31.15% | 2.78TCr | |
+8.08% | 1.91TCr | |
+15.01% | 1.7TCr | |
-10.17% | 1.52TCr | |
-26.60% | 1.48TCr | |
-29.71% | 1.2TCr |
- Stock Market
- Equities
- TATVA Stock
- News Tatva Chintan Pharma Chem Limited
- Transcript : Tatva Chintan Pharma Chem Limited, Q4 2023 Earnings Call, May 05, 2023